Aicuris Reveals Pritelivir Phase 2 Success And AIC468 Safety Data
20 Oct 2025 //
GLOBENEWSWIRE
Aicuris’ Pritelivir Meets Ph3 Endpoint in Refractory HSV
16 Oct 2025 //
GLOBENEWSWIRE
Aicuris to Present Orally and via Poster at ID Week 2025
16 Sep 2025 //
GLOBENEWSWIRE
Aicuris Completes Enrollment for Pritelivir Herpes Trial
24 Jul 2025 //
GLOBENEWSWIRE
AiCuris was Granted Breakthrough Therapy Designation by U.S. FDA for Pritelivir
06 Jun 2020 //
APNEWS

Market Place
Sourcing Support